JOHN CROUSE

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study
    Hunter R Underhill
    Department of Radiology University of Washington, Seattle, WA, USA
    J Cardiovasc Magn Reson 10:31. 2008
  2. ncbi A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
    J R Crouse
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Arch Intern Med 159:2070-6. 1999
  3. ncbi Effects of statins on carotid disease and stroke
    J R Crouse
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Curr Opin Lipidol 10:535-41. 1999
  4. ncbi Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study
    John Robert Crouse
    Department of Medicine, Section on Endocrinology Metabolism, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Cardiovasc Drugs Ther 18:231-8. 2004
  5. ncbi Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art
    John R Crouse
    Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    J Lipid Res 47:1677-99. 2006
  6. ncbi Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study
    John R Crouse
    Wake Forest University, Winston Salem, NC 27157, USA
    Curr Med Res Opin 23:641-8. 2007
  7. ncbi Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial
    John R Crouse
    Department of Medicine, Wake Forest University, Winston Salem, NC 27157, USA
    JAMA 297:1344-53. 2007
  8. ncbi An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability
    John R Crouse
    Professor of Medicine and Public Health Sciences Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Expert Opin Drug Metab Toxicol 4:287-304. 2008
  9. ncbi Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study
    John R Crouse
    Department of aMedicine, Wake Forest University, Winston Salem, North Carolina 27157, USA
    Eur J Cardiovasc Prev Rehabil 17:223-9. 2010

Research Grants

  1. CORONARY CALCIFICATION PROGRESSION STUDY
    JOHN CROUSE; Fiscal Year: 2001
  2. Carotid Atherosclerosis (MRI) Progression Study (CAMP)
    JOHN CROUSE; Fiscal Year: 2007

Collaborators

Detail Information

Publications9

  1. ncbi Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study
    Hunter R Underhill
    Department of Radiology University of Washington, Seattle, WA, USA
    J Cardiovasc Magn Reson 10:31. 2008
    ....
  2. ncbi A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
    J R Crouse
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Arch Intern Med 159:2070-6. 1999
    ..Isolated soy protein reduces plasma concentrations of total and low-density lipoprotein (LDL) cholesterol...
  3. ncbi Effects of statins on carotid disease and stroke
    J R Crouse
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Curr Opin Lipidol 10:535-41. 1999
    ....
  4. ncbi Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study
    John Robert Crouse
    Department of Medicine, Section on Endocrinology Metabolism, Wake Forest University School of Medicine, Medical Center Blvd, Winston Salem, NC 27157, USA
    Cardiovasc Drugs Ther 18:231-8. 2004
    ....
  5. ncbi Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art
    John R Crouse
    Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    J Lipid Res 47:1677-99. 2006
    ..CT and MRI technology are advancing very rapidly, and research and clinical uses of these imaging modalities promise to further advance our understanding of atherosclerosis and its prevention...
  6. ncbi Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study
    John R Crouse
    Wake Forest University, Winston Salem, NC 27157, USA
    Curr Med Res Opin 23:641-8. 2007
    ..We present baseline data from the METEOR study, a randomized, placebo-controlled trial evaluating the efficacy of rosuvastatin 40 mg on changes in CIMT. We set out to compare differences in CIMT between several subgroups of individuals...
  7. ncbi Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial
    John R Crouse
    Department of Medicine, Wake Forest University, Winston Salem, NC 27157, USA
    JAMA 297:1344-53. 2007
    ..Atherosclerosis is often advanced before symptoms appear and it is not clear whether treatment is beneficial in middle-aged individuals with a low Framingham risk score (FRS) and mild to moderate subclinical atherosclerosis...
  8. ncbi An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability
    John R Crouse
    Professor of Medicine and Public Health Sciences Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Expert Opin Drug Metab Toxicol 4:287-304. 2008
    ..The HMG Co-A reductase inhibitors (statins) are the most efficacious agents for lowering cholesterol. Statins reduce clinical cardiovascular events and are generally well tolerated...
  9. ncbi Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study
    John R Crouse
    Department of aMedicine, Wake Forest University, Winston Salem, North Carolina 27157, USA
    Eur J Cardiovasc Prev Rehabil 17:223-9. 2010
    ....

Research Grants8

  1. CORONARY CALCIFICATION PROGRESSION STUDY
    JOHN CROUSE; Fiscal Year: 2001
    ..They point out that pilot data support the feasibility and likely informativeness of this study. ..
  2. Carotid Atherosclerosis (MRI) Progression Study (CAMP)
    JOHN CROUSE; Fiscal Year: 2007
    This is an application for a collaboration between Wake Forest University School of Medicine (WFU, Dr. John Crouse) and the University of Washington (U Wash, Dr...